Exploring the Intersection of Schizophrenia, Machine Learning, and Genomics: A Scoping Review (Preprint) DOI Creative Commons
Alexandre Hudon, Mélissa Beaudoin, Kingsada Phraxayavong

et al.

JMIR Bioinformatics and Biotechnology, Journal Year: 2024, Volume and Issue: 5, P. e62752 - e62752

Published: Oct. 16, 2024

An increasing body of literature highlights the integration machine learning with genomic data in psychiatry, particularly for complex mental health disorders such as schizophrenia. These advanced techniques offer promising potential uncovering various facets these disorders. A comprehensive review current applications conjunction within this context can significantly enhance our understanding state research and its future directions.

Language: Английский

Exploring the Intersection of Schizophrenia, Machine Learning, and Genomics: A Scoping Review (Preprint) DOI Creative Commons
Alexandre Hudon, Mélissa Beaudoin, Kingsada Phraxayavong

et al.

Published: May 30, 2024

BACKGROUND An increasing body of literature highlights the integration machine learning with genomic data in psychiatry, particularly for complex mental health disorders such as schizophrenia. These advanced techniques offer promising potential uncovering various facets these disorders. A comprehensive review current applications conjunction within this context can significantly enhance our understanding state research and its future directions. OBJECTIVE The objective study is to conduct a systematic scoping use algorithms field METHODS systematic, review, search was performed electronic databases Medline, Web Science, PsycNet (PsycINFO), Google Scholar from 2013 2024. Studies at intersection schizophrenia, data, were evaluated. RESULTS identified 2437 eligible articles after removing duplicates. Following abstract screening, 143 full-text assessed, 121 subsequently excluded. Therefore, 21 studies thoroughly assessed. Various used studies, support vector machines being most common. notably predict identifying schizophrenia features, discovering drugs, classifying amongst other disorders, predicting quality-of-life patients. CONCLUSIONS Several high-quality identified. Yet, application remains limited. Future essential further evaluate portability models explore their clinical applications.

Language: Английский

Citations

0

Antipsychotics DOI

Kalliopi Vallianatou

Medicine, Journal Year: 2024, Volume and Issue: 52(9), P. 573 - 576

Published: July 26, 2024

Citations

0

‘Whole-Body’ Perspectives of Schizophrenia and Related Psychotic Illness: miRNA-143 as an Exemplary Molecule Implicated across Multi-System Dysfunctions DOI Creative Commons

J.L. Waddington,

Xiaoyu Wang, Xuechu Zhen

et al.

Biomolecules, Journal Year: 2024, Volume and Issue: 14(9), P. 1185 - 1185

Published: Sept. 20, 2024

A wide array of biological abnormalities in psychotic illness appear to reflect non-cerebral involvement. This review first outlines the evidence for such a whole-body concept schizophrenia pathobiology, focusing particularly on cardiovascular disease, metabolic syndrome and diabetes, immunity inflammation, cancer, gut–brain axis. It then considers roles miRNAs general miRNA-143 particular as they relate epidemiology, treatment schizophrenia. is followed by notable that also implicated each these domains Thus, an exemplar what may be class molecules play role across multiple bodily dysfunction characterize perspective Importantly, existence exemplary molecule implies coordinated rather than stochastic basis. One candidate process would pleiotropic effect genetic risk whole body.

Language: Английский

Citations

0

Neurovascular coupling of striatal dopamine D2/3 receptor availability and perfusion using simultaneous PET/MR in humans DOI Creative Commons
Christian N. Schmitz, X.M. Hart, Moritz Spangemacher

et al.

Neuroscience Applied, Journal Year: 2024, Volume and Issue: 3, P. 104094 - 104094

Published: Jan. 1, 2024

Language: Английский

Citations

0

Exploring the Intersection of Schizophrenia, Machine Learning, and Genomics: A Scoping Review (Preprint) DOI Creative Commons
Alexandre Hudon, Mélissa Beaudoin, Kingsada Phraxayavong

et al.

JMIR Bioinformatics and Biotechnology, Journal Year: 2024, Volume and Issue: 5, P. e62752 - e62752

Published: Oct. 16, 2024

An increasing body of literature highlights the integration machine learning with genomic data in psychiatry, particularly for complex mental health disorders such as schizophrenia. These advanced techniques offer promising potential uncovering various facets these disorders. A comprehensive review current applications conjunction within this context can significantly enhance our understanding state research and its future directions.

Language: Английский

Citations

0